204 related articles for article (PubMed ID: 19533338)
1. Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells.
De Amicis F; Thirugnansampanthan J; Cui Y; Selever J; Beyer A; Parra I; Weigel NL; Herynk MH; Tsimelzon A; Lewis MT; Chamness GC; Hilsenbeck SG; Andò S; Fuqua SA
Breast Cancer Res Treat; 2010 May; 121(1):1-11. PubMed ID: 19533338
[TBL] [Abstract][Full Text] [Related]
2. Hormonal modulation of ESR1 mutant metastasis.
Gu G; Tian L; Herzog SK; Rechoum Y; Gelsomino L; Gao M; Du L; Kim JA; Dustin D; Lo HC; Beyer AR; Edwards DG; Gonzalez T; Tsimelzon A; Huang HJ; Fernandez NM; Grimm SL; Hilsenbeck SG; Liu D; Xu J; Alaniz A; Li S; Mills GB; Janku F; Kittler R; Zhang XH; Coarfa C; Foulds CE; Symmans WF; Andò S; Fuqua SAW
Oncogene; 2021 Feb; 40(5):997-1011. PubMed ID: 33323970
[TBL] [Abstract][Full Text] [Related]
3. Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer.
Bahnassy S; Thangavel H; Quttina M; Khan AF; Dhanyalayam D; Ritho J; Karami S; Ren J; Bawa-Khalfe T
Cell Commun Signal; 2020 Sep; 18(1):154. PubMed ID: 32948192
[TBL] [Abstract][Full Text] [Related]
4. Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.
Cochrane DR; Bernales S; Jacobsen BM; Cittelly DM; Howe EN; D'Amato NC; Spoelstra NS; Edgerton SM; Jean A; Guerrero J; Gómez F; Medicherla S; Alfaro IE; McCullagh E; Jedlicka P; Torkko KC; Thor AD; Elias AD; Protter AA; Richer JK
Breast Cancer Res; 2014 Jan; 16(1):R7. PubMed ID: 24451109
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer.
Ciupek A; Rechoum Y; Gu G; Gelsomino L; Beyer AR; Brusco L; Covington KR; Tsimelzon A; Fuqua SA
Breast Cancer Res Treat; 2015 Nov; 154(2):225-37. PubMed ID: 26487496
[TBL] [Abstract][Full Text] [Related]
6. AR collaborates with ERα in aromatase inhibitor-resistant breast cancer.
Rechoum Y; Rovito D; Iacopetta D; Barone I; Andò S; Weigel NL; O'Malley BW; Brown PH; Fuqua SA
Breast Cancer Res Treat; 2014 Oct; 147(3):473-85. PubMed ID: 25178514
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.
Peters AA; Buchanan G; Ricciardelli C; Bianco-Miotto T; Centenera MM; Harris JM; Jindal S; Segara D; Jia L; Moore NL; Henshall SM; Birrell SN; Coetzee GA; Sutherland RL; Butler LM; Tilley WD
Cancer Res; 2009 Aug; 69(15):6131-40. PubMed ID: 19638585
[TBL] [Abstract][Full Text] [Related]
8. Multiple molecular subtypes of triple-negative breast cancer critically rely on androgen receptor and respond to enzalutamide in vivo.
Barton VN; D'Amato NC; Gordon MA; Lind HT; Spoelstra NS; Babbs BL; Heinz RE; Elias A; Jedlicka P; Jacobsen BM; Richer JK
Mol Cancer Ther; 2015 Mar; 14(3):769-78. PubMed ID: 25713333
[TBL] [Abstract][Full Text] [Related]
9. Targeting the androgen receptor in breast cancer.
Chia K; O'Brien M; Brown M; Lim E
Curr Oncol Rep; 2015 Feb; 17(2):4. PubMed ID: 25665553
[TBL] [Abstract][Full Text] [Related]
10. Cooperative Dynamics of AR and ER Activity in Breast Cancer.
D'Amato NC; Gordon MA; Babbs B; Spoelstra NS; Carson Butterfield KT; Torkko KC; Phan VT; Barton VN; Rogers TJ; Sartorius CA; Elias A; Gertz J; Jacobsen BM; Richer JK
Mol Cancer Res; 2016 Nov; 14(11):1054-1067. PubMed ID: 27565181
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor in estrogen receptor positive breast cancer: Beyond expression.
Basile D; Cinausero M; Iacono D; Pelizzari G; Bonotto M; Vitale MG; Gerratana L; Puglisi F
Cancer Treat Rev; 2017 Dec; 61():15-22. PubMed ID: 29078133
[TBL] [Abstract][Full Text] [Related]
12. Complexities of androgen receptor signalling in breast cancer.
McNamara KM; Moore NL; Hickey TE; Sasano H; Tilley WD
Endocr Relat Cancer; 2014 Aug; 21(4):T161-81. PubMed ID: 24951107
[TBL] [Abstract][Full Text] [Related]
13. Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?
Hickey TE; Robinson JL; Carroll JS; Tilley WD
Mol Endocrinol; 2012 Aug; 26(8):1252-67. PubMed ID: 22745190
[TBL] [Abstract][Full Text] [Related]
14. Triple-negative breast cancer: role of the androgen receptor.
Gucalp A; Traina TA
Cancer J; 2010; 16(1):62-5. PubMed ID: 20164692
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer.
Hilborn E; Gacic J; Fornander T; Nordenskjöld B; Stål O; Jansson A
Br J Cancer; 2016 Feb; 114(3):248-55. PubMed ID: 26742006
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis.
Vera-Badillo FE; Templeton AJ; de Gouveia P; Diaz-Padilla I; Bedard PL; Al-Mubarak M; Seruga B; Tannock IF; Ocana A; Amir E
J Natl Cancer Inst; 2014 Jan; 106(1):djt319. PubMed ID: 24273215
[TBL] [Abstract][Full Text] [Related]
17. Germline Variant in HSD3B1 (1245 A > C) and Response to Abiraterone Acetate Plus Prednisone in Men With New-Onset Metastatic Castration-Resistant Prostate Cancer.
Hahn AW; Gill DM; Nussenzveig RH; Poole A; Farnham J; Cannon-Albright L; Agarwal N
Clin Genitourin Cancer; 2018 Aug; 16(4):288-292. PubMed ID: 29674118
[TBL] [Abstract][Full Text] [Related]
18. AR Signaling in Breast Cancer.
Rahim B; O'Regan R
Cancers (Basel); 2017 Feb; 9(3):. PubMed ID: 28245550
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1.
Robinson JL; Macarthur S; Ross-Innes CS; Tilley WD; Neal DE; Mills IG; Carroll JS
EMBO J; 2011 Jun; 30(15):3019-27. PubMed ID: 21701558
[TBL] [Abstract][Full Text] [Related]
20. Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer.
Ali A; Creevey L; Hao Y; McCartan D; O'Gaora P; Hill A; Young L; McIlroy M
Breast Cancer Res; 2015 Sep; 17(1):123. PubMed ID: 26341737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
